Direct answer
Dental implants can sometimes be placed in patients who have received head and neck radiation, but outcomes and osteoradionecrosis risk depend on jaw dose, location, time since treatment, tissue condition, smoking, surgery extent, and cancer status. The radiation plan or dosimetry should be reviewed whenever possible before elective implant or graft surgery.
Key takeaways
- Radiation dose to the specific implant site is more useful than the statement “I had radiation.”
- Osteoradionecrosis can occur years after treatment because radiation causes lasting changes in bone and soft tissue.
- Implant survival is generally lower in irradiated bone than in nonirradiated sites, with risk varying by dose and anatomy.
- The 2024 ISOO-MASCC-ASCO guideline found limited justification for routine hyperbaric oxygen and insufficient evidence for some proposed adjuncts.
- Dry mouth, caries risk, trismus, nutrition, and ability to maintain the prosthesis are as important as integration.
Evidence and decision snapshot
| Question | Established role | Possible value | Important limitation |
|---|---|---|---|
| Site outside meaningful radiation field | Implant planning may resemble routine care. | Restores function without operating in heavily affected bone. | Dosimetry should be confirmed rather than assumed. |
| Moderate or high jaw dose | Risk assessment and specialist coordination are important. | Selected cases may still be treated. | ORN, failure, wound breakdown, and graft risk increase. |
| Active ORN or nonhealing wound | Reconstruction focuses on disease management. | Specialist treatment may restore health and function. | Elective implant placement is not the immediate priority. |
| Hyperbaric oxygen | May be considered selectively. | Some clinicians use it in high-risk scenarios. | Current guideline evidence does not support routine use for all patients. |
Why radiation has long-term effects
Radiation can injure small blood vessels, bone-forming cells, soft tissue, salivary glands, muscles, and mucosa. These effects may produce fibrosis, reduced vascularity, dry mouth, trismus, caries, and impaired wound repair. The risk does not disappear after a fixed number of years.
Osteoradionecrosis is exposed or nonhealing irradiated jawbone without recurrent tumor as the cause. It can follow extraction, implant surgery, denture trauma, or occur without a clear procedure. Prevention begins with knowing the dose and controlling oral disease.
Obtaining the radiation map
The oncology summary should identify the tumor, treatment dates, total dose, modality, and fields. Modern plans can provide dose-volume information for the mandible and maxilla. A total neck dose does not reveal what a specific molar or anterior site received.
When records are unavailable, the clinician should not pretend the risk is known. The tumor location and treatment technique may provide clues, but uncertainty should be part of consent and may favor a non-surgical or less extensive option.
Implant survival and dose
Systematic reviews generally report lower implant survival in irradiated patients than in nonirradiated controls, but outcomes vary widely. Dose, timing, grafted bone, smoking, hygiene, prosthesis design, and patient selection differ among studies. Mandibular and maxillary sites may behave differently.
An implant that integrates is not the only outcome. Late peri-implantitis or removal can create an additional bone wound in irradiated tissue. Long-term maintenance and the ability to treat future complications should influence whether an implant is placed.
Timing and surgical scope
No single waiting period guarantees safety. Some implants are placed before radiation, others during ablative reconstruction, and others after treatment. The best timing depends on cancer prognosis, tissue recovery, dose, and rehabilitation plan. Extensive grafting adds biologic demand and may require a multidisciplinary cancer center.
When feasible, a limited staged approach may be more prudent than multiple simultaneous extractions, grafts, and implants. A removable prosthesis may be preferable if surgery would produce disproportionate risk, although denture trauma must also be controlled.
Hyperbaric oxygen and other adjuncts
The 2024 ISOO-MASCC-ASCO guideline concluded that routine hyperbaric oxygen for prevention or management of ORN is largely unjustified by current evidence. That does not mean it is never used, but it should not be marketed as a guaranteed prerequisite or cure.
The guideline also found insufficient evidence to recommend leukocyte- and platelet-rich fibrin or photobiomodulation for ORN prevention. Sound surgical planning, risk reduction, and established management remain more important than relying on an adjunct.
Survivorship, dry mouth, and maintenance
Radiation-related salivary damage can dramatically increase caries and mucosal injury. Fluoride, saliva management, dietary counseling, and frequent preventive visits may determine whether the remaining teeth and implant restoration survive. Trismus may limit surgery and cleaning access.
A fixed prosthesis should not be chosen solely because it avoids a removable denture. If the patient cannot clean beneath it or open sufficiently for maintenance, the long-term risk may be unacceptable. Rehabilitation should be coordinated with oncology, oral medicine, prosthodontics, and maxillofacial surgery when complexity is high.
Frequently asked questions
How much radiation is too much for an implant?
There is no universally safe cutoff. Risk rises with dose and other factors, and the dose at the exact site should be reviewed.
Does waiting five years remove the risk?
No. Late radiation effects and osteoradionecrosis risk can persist for life.
Do I need hyperbaric oxygen?
Not routinely. Current guideline evidence does not support universal use, though a specialist may consider it in selected circumstances.
Can an implant be removed from irradiated bone?
Sometimes, but removal is another bone-invasive procedure and may carry ORN risk. Prevention and early management of peri-implant disease are especially important.
Are ceramic implants safer in irradiated bone?
There is no convincing evidence that zirconia removes radiation-related vascular and healing risks.
Questions to discuss with your implant team
- What dose did the proposed implant site receive?
- Are there current signs of ORN, fibrosis, dry mouth, or trismus?
- Is cancer controlled and is further treatment expected?
- Can the plan be simplified or staged?
- Who will provide long-term maintenance and manage a future complication?
What this means for patients: A history of head and neck radiation requires site-specific dosimetry and lifelong risk awareness. Treatment may be possible, but dose, tissue condition, surgical extent, maintenance ability, and alternatives must be considered. No adjunct or implant material eliminates radiation injury.
Selected references
- Peterson DE, Koyfman SA, Yarom N, et al. Prevention and management of osteoradionecrosis in patients with head and neck cancer treated with radiation therapy: ISOO-MASCC-ASCO guideline. J Clin Oncol. 2024;42(16):1975-1996. doi:10.1200/JCO.23.02750. View source.
- MASCC. ISOO-MASCC-ASCO Guideline: Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy. May 2024. View source.
- Schimmel M, Srinivasan M, McKenna G, Müller F. Effect of advanced age and/or systemic medical conditions on dental implant survival. Clin Oral Implants Res. 2018;29 Suppl 16:311-330. View source.
- Chrcanovic BR, Albrektsson T, Wennerberg A. Dental implants in irradiated versus nonirradiated patients: a meta-analysis. Head Neck. 2016;38(3):448-481. View source.
- American Dental Association. Cancer (Head and Neck) and Cancer Therapies and Dental Considerations. ADA Oral Health Topics. Accessed July 28, 2026. View source.